Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced the closing of the $25M final tranche to its Series B ...
The music industry's uptake of AI complicates the boundaries between listener, artist and music in troubling new ways, argues ...
Maison&Objet Intérieurs Hong Kong returned to the Hong Kong Convention and Exhibition Centre from 3–6 December 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback